CRISPR Therapeutics: I Love The Medical Breakthroughs, I Don't Love The Stock (CRSP)
· seekingalpha.com
CRISPR Therapeutics looks overvalued despite Casgevy sales growth.
There is no doubt in my mind that CRISPR Therapeutics ( CRSP ) has provided the world with incredible medical breakthroughs, but that doesn't mean that the stoc...